Disruption of cellular immune response among male rotating night shift workers in Spain- The HORMONIT study.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 14 09 2021
accepted: 09 08 2022
entrez: 19 9 2022
pubmed: 20 9 2022
medline: 21 9 2022
Statut: epublish

Résumé

Preliminary studies suggest that night shift work is associated with a desynchronization of rhythmic immune markers, possibly explaining the increased risk of infection, cardiometabolic disorders, and cancer in shift workers. This study included 51 male rotating shift workers from a car industry in Barcelona, Spain, sampled twice toward the end of a 3-week night shift (22:00-06:00 h) and a 3-week day shift (06:00-14:00 h) rotation. We collected four blood samples per worker, at the start and end of each shift. We measured 27 cytokines, chemokines and growth factors in plasma samples by luminex using the Cytokine Human Magnetic 30-Plex Panel LHC6003M and applied linear mixed models to examine within-person associations between shift work and analytes' concentrations, comparing samples taken at 06:00 h on a day and night shift. We also conducted a factor analysis using analyte concentrations from all 4 time points for each individual to identify common factors and determine if these factors were altered by shift work. We observed lower levels of 15 analytes in the night shift compared to the day shift including cytokines (pro-inflammatory TNF-α, IL-2R; anti-inflammatory IL1-RA; Th1 IL-2, Th2 IL-4 and Th17 Il-17), chemokines (IP-10, MIP-1α, MIP-1β, RANTES) and growth factors (EGF, G-CSF, HGF, VEGF, FGF). In a factor analysis, three factors were identified. The main factor (Factor 1), explaining 57% of the variance and including IL-1β, IL-12, IL-15, MIP-1α, MIP-1β, EGF and FGF; and another factor (Factor 3) explaining 10% of the variance and including the Th1 cytokine IL-12, were inversely associated with the night shift (coefficient: -0.17, 95%CI -0.32 to -0.01 and coefficient: -0.22, 95%CI -0.38, -0.06, for Factors 1 and 3, respectively). Our results indicate that night shift disrupts the levels of several immune markers, which could contribute to the increased risk of infections and cancer reported in night shift workers. Night shift is associated with disruption of multiple immune response pathways.

Identifiants

pubmed: 36119067
doi: 10.3389/fimmu.2022.776917
pmc: PMC9478612
doi:

Substances chimiques

Chemokine CCL3 0
Chemokine CCL4 0
Chemokine CCL5 0
Chemokine CXCL10 0
Cytokines 0
Interleukin-15 0
Interleukin-17 0
Interleukin-2 0
Tumor Necrosis Factor-alpha 0
Vascular Endothelial Growth Factor A 0
Granulocyte Colony-Stimulating Factor 143011-72-7
Interleukin-12 187348-17-0
Interleukin-4 207137-56-2
Epidermal Growth Factor 62229-50-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

776917

Informations de copyright

Copyright © 2022 Harding, Aguilar, Espinosa, Castaño-Vinyals, Papantoniou, Navarrete, Such Faro, Torrejón, Dobaño, Moncunill and Kogevinas.

Déclaration de conflit d'intérêts

JN, PF and AT work at the Occupational Health service of the car factory, which was the setting of the present study. At the HORMONIT study working group they express their own views and do not represent the company. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Allergy Clin Immunol. 1975 Sep;56(3):191-205
pubmed: 1151013
Ann N Y Acad Sci. 1962 Oct 30;98:969-83
pubmed: 13969762
Curr Opin Pharmacol. 2021 Apr;57:60-70
pubmed: 33340915
PLoS One. 2011;6(12):e29801
pubmed: 22216357
Eur Arch Psychiatry Clin Neurosci. 1992;242(1):53-6
pubmed: 1390956
Sci Rep. 2017 Sep 6;7(1):10717
pubmed: 28878235
PLoS One. 2014 Feb 27;9(2):e90149
pubmed: 24587250
Neurobiol Sleep Circadian Rhythms. 2021 Mar 05;10:100063
pubmed: 33748539
Nat Rev Immunol. 2013 Mar;13(3):190-8
pubmed: 23391992
Sci Rep. 2019 Dec 3;9(1):18220
pubmed: 31796836
PLoS Negl Trop Dis. 2021 Mar 5;15(3):e0009223
pubmed: 33667232
Front Cell Infect Microbiol. 2020 Mar 13;10:96
pubmed: 32232012
Nat Commun. 2020 Jun 24;11(1):3193
pubmed: 32581213
Chronobiol Int. 2020 May;37(5):607-617
pubmed: 32432519
Sleep Med. 2020 Nov;75:263-275
pubmed: 32866895
Brain Behav Immun. 2015 Jul;47:4-13
pubmed: 25452149
J Transl Med. 2015 Apr 24;13:129
pubmed: 25903806
J Occup Environ Med. 2002 Nov;44(11):1003-11
pubmed: 12449906
Front Public Health. 2020 Sep 14;8:415
pubmed: 33042933
Proc Natl Acad Sci U S A. 2018 May 22;115(21):5540-5545
pubmed: 29735673
Front Neurol. 2019 Apr 11;10:356
pubmed: 31031690
Immunol Rev. 2018 May;283(1):176-193
pubmed: 29664568
J Biol Rhythms. 2013 Apr;28(2):130-40
pubmed: 23606612
Malar J. 2019 Dec 5;18(1):406
pubmed: 31806027
J Immunol. 2016 Mar 15;196(6):2466-75
pubmed: 26873990
JCI Insight. 2020 Jan 16;5(1):
pubmed: 31941836
J Immunol. 1981 Apr;126(4):1360-3
pubmed: 6970770
In Vivo. 1995 Jul-Aug;9(4):331-9
pubmed: 8555432
Lancet Oncol. 2019 Aug;20(8):1058-1059
pubmed: 31281097
Brain Behav Immun. 2012 Mar;26(3):407-13
pubmed: 22019350
Best Pract Res Clin Endocrinol Metab. 2010 Oct;24(5):775-84
pubmed: 21112025
Am J Physiol. 1992 May;262(5 Pt 2):R885-91
pubmed: 1590482
Cell Metab. 2017 Mar 7;25(3):506-521
pubmed: 28273474
Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):582-7
pubmed: 22184247
BMC Med. 2018 Nov 2;16(1):198
pubmed: 30384846
PLoS Pathog. 2010 Feb 26;6(2):e1000661
pubmed: 20195505
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13812-7
pubmed: 11095721
Circ Res. 2016 Jun 24;119(1):113-30
pubmed: 27340271
Int J Epidemiol. 2018 Dec 1;47(6):1956-1971
pubmed: 29850840
Scand J Work Environ Health. 2022 Jan 1;48(1):41-51
pubmed: 34623452
Nat Rev Immunol. 2018 Jul;18(7):423-437
pubmed: 29662121
South Med J. 2017 Apr;110(4):314-317
pubmed: 28376532
Chronobiol Int. 2017;34(6):721-731
pubmed: 28488901
Pflugers Arch. 2012 Jan;463(1):121-37
pubmed: 22071480
Science. 1995 Sep 15;269(5230):1583-5
pubmed: 7667639
J Biol Rhythms. 2003 Feb;18(1):80-90
pubmed: 12568247
Chronobiol Int. 1995 Feb;12(1):19-27
pubmed: 7750154
Cytokine Growth Factor Rev. 2017 Dec;38:10-21
pubmed: 28888485
Cells. 2021 Nov 19;10(11):
pubmed: 34831463
Nat Rev Immunol. 2002 Jan;2(1):37-45
pubmed: 11905836
J Biol Rhythms. 2015 Aug;30(4):277-90
pubmed: 25900041
Multivariate Behav Res. 1969 Jul 1;4(3):375-7
pubmed: 26745847
Sleep Sci. 2016 Jul-Sep;9(3):164-168
pubmed: 28123655
Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21407-12
pubmed: 19955445
Circ Res. 2016 Jun 24;119(1):131-41
pubmed: 27340272
Eur J Immunol. 2006 Feb;36(2):371-9
pubmed: 16453387
Int J Cancer. 2015 Sep 1;137(5):1147-57
pubmed: 25530021
Circ Res. 2016 Jun 24;119(1):159-76
pubmed: 27340274
Circ Res. 2016 Jun 24;119(1):142-58
pubmed: 27340273

Auteurs

Barbara N Harding (BN)

Department of Non-Communicable Diseases and Environment, Barcelona Institue of Global Health (ISGlobal), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Publica (CIBERESP), Madrid, Spain.

Ruth Aguilar (R)

Barcelona Institue of Global Health (ISGlobal), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.

Ana Espinosa (A)

Department of Non-Communicable Diseases and Environment, Barcelona Institue of Global Health (ISGlobal), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Publica (CIBERESP), Madrid, Spain.

Gemma Castaño-Vinyals (G)

Department of Non-Communicable Diseases and Environment, Barcelona Institue of Global Health (ISGlobal), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Publica (CIBERESP), Madrid, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Kyriaki Papantoniou (K)

Department of Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria.

José Maria Navarrete (JM)

Health, Safety and Emergencies of SEAT, CUPRA and the Volkswagen Group Companies in Spain, Barcelona, Spain.

Patricia Such Faro (P)

Health, Safety and Emergencies of SEAT, CUPRA and the Volkswagen Group Companies in Spain, Barcelona, Spain.

Antonio Torrejón (A)

Health, Safety and Emergencies of SEAT, CUPRA and the Volkswagen Group Companies in Spain, Barcelona, Spain.

Carlota Dobaño (C)

Barcelona Institue of Global Health (ISGlobal), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
CIBER de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain.

Gemma Moncunill (G)

Barcelona Institue of Global Health (ISGlobal), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
CIBER de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain.

Manolis Kogevinas (M)

Department of Non-Communicable Diseases and Environment, Barcelona Institue of Global Health (ISGlobal), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER Epidemiología y Salud Publica (CIBERESP), Madrid, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH